Australia regulator approves Pfizer/BioNTech Covid-19 vaccine for use
[SYDNEY] Australia's therapeutic goods regulator has conditionally approved the Pfizer/BioNTech Covid-19 vaccine for use after determining that it met strict standards for safety, quality and efficacy, the federal government said on Monday.
The Therapeutic Goods Administration's (TGA) provisional approval is for people aged over 16, and a priority group of Australians would receive their first of two doses of the vaccine once received from the drugmaker, the government added.
"I welcome the TGA's approval of the Pfizer vaccine, with our own Australian experts finding it is safe, effective and of a high standard," Prime Minister Scott Morrison said in a statement.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Economic leaders of South Korea, Japan, China say FX volatility is a risk
US automakers win extension on use of Chinese graphite in EV tax credits
US service sector contracts in April; price pressures up
Thaksin’s daughter calls central bank independence an ‘obstacle’
US jobs growth slows in April; jobless rate up to 3.9%
Magnitude 6.0 quake strikes Philippines, aftershocks and damage expected